2015
DOI: 10.1016/j.atherosclerosis.2015.04.084
|View full text |Cite
|
Sign up to set email alerts
|

Elevated lipoprotein(a) and hs-CRP as a poor prognostic marker in patients with coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Lipid abnormalities and inflammation are the main pathological changes of atherosclerosis, and their simultaneous detection can more accurately predict the progression of atherosclerosis 15–17 . In primary and secondary prevention of CVD, according to Mangalmurti and Davidson, lipid biomarkers, such as Apo B, LDL‐P, and Lp(a), may have clinical utility, and inflammatory markers, such as hs‐CRP, may be useful for evaluating residual risk 18 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Lipid abnormalities and inflammation are the main pathological changes of atherosclerosis, and their simultaneous detection can more accurately predict the progression of atherosclerosis 15–17 . In primary and secondary prevention of CVD, according to Mangalmurti and Davidson, lipid biomarkers, such as Apo B, LDL‐P, and Lp(a), may have clinical utility, and inflammatory markers, such as hs‐CRP, may be useful for evaluating residual risk 18 .…”
Section: Discussionmentioning
confidence: 99%
“…Numerous clinical studies have confirmed that hs‐CRP and Lp(a) are poor prognostic markers in patients with coronary artery disease and are independent risk factors for CHD events 3–7,15 . Clinically, many commercialized kits are available for detecting serum levels of hs‐CRP and Lp(a) to assess the risk of CHD events.…”
Section: Discussionmentioning
confidence: 99%